A detailed history of Massachusetts Financial Services CO transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Massachusetts Financial Services CO holds 5,580 shares of IONS stock, worth $263,599. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,580
Previous 5,592 0.21%
Holding current value
$263,599
Previous $282,000 14.54%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$42.03 - $53.55 $504 - $642
-12 Reduced 0.21%
5,580 $241,000
Q4 2023

Feb 08, 2024

SELL
$43.39 - $51.63 $7,680 - $9,138
-177 Reduced 3.07%
5,592 $282,000
Q3 2023

Nov 08, 2023

SELL
$38.5 - $47.13 $799,260 - $978,418
-20,760 Reduced 78.25%
5,769 $261,000
Q2 2023

Aug 09, 2023

SELL
$34.73 - $43.33 $21,671 - $27,037
-624 Reduced 2.3%
26,529 $1.09 Million
Q1 2023

May 10, 2023

BUY
$33.58 - $41.2 $911,797 - $1.12 Million
27,153 New
27,153 $970,000

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $6.71B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Massachusetts Financial Services CO Portfolio

Follow Massachusetts Financial Services CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Massachusetts Financial Services CO , based on Form 13F filings with the SEC.

News

Stay updated on Massachusetts Financial Services CO with notifications on news.